10 /100
LOW RISK
Score updated Jul 13, 2026

DOX — Amdocs Limited Dilution Risk Tracker

Track DOX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DOX — Get alerts when the score changes →

As of July 13, 2026, Amdocs Limited (DOX) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Amdocs Limited has a market capitalization of $6.69B, 112.89M shares outstanding, 484 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
19
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for DOX.
🔔 Track DOX — Get forecast alerts →

💹 Market Data

Market Cap$6.69B
Shares Outstanding112.89M
Float103.89M
Cash$346.08M
Debt$646.29M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 4.7% shares (2026Q1 vs prior)
484 institutional holders · 112.66M shares
#1 PZENA INVESTMENT MANAGEMENT LLC 12.68M shares
#2 FMR LLC 11.42M shares
#3 Beutel, Goodman & Co Ltd. 5.28M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest9.56M
Days to Cover4.3
% of Float9.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Sep 30, 2010
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for DOX Shareholders

Amdocs Limited (DOX) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for DOX shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for DOX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for DOX alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track DOX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DOX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for DOX
📊 DOX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DOX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.